Poolbeg Pharma (LSE:POLB) Interest Expense : £0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Poolbeg Pharma's interest expense for the six months ended in Jun. 2024 was £ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was £0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Poolbeg Pharma's Operating Income for the six months ended in Jun. 2024 was £ -2.53 Mil. Poolbeg Pharma's Interest Expense for the six months ended in Jun. 2024 was £ 0.00 Mil. Poolbeg Pharma has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Poolbeg Pharma Interest Expense Historical Data

The historical data trend for Poolbeg Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Interest Expense Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Interest Expense

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial			-	-	-	-	-

Poolbeg Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Poolbeg Pharma (LSE:POLB) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Poolbeg Pharma's Interest Expense for the six months ended in Jun. 2024 was £0.00 Mil. Its Operating Income for the six months ended in Jun. 2024 was £-2.53 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was £0.00 Mil.

Poolbeg Pharma's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Poolbeg Pharma had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Poolbeg Pharma PLC has no debt.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (LSE:POLB) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

7JN:Germany

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines